Citations

Showing 10 of 108104 citations.

Comparative Outcomes of Radial and Bucket-Handle Meniscal Tear Repair: A Propensity-Matched Analysis
Wu, Isabella T. , Desai, Vishal S. , Dahm, Diane L., Levy, Bruce A. , Krych, Aaron J. , Krych, Aaron J , Hevesi, Mario , Desai, Vishal , Camp, Christopher L. , Stuart, Michael J.

Mayo Clinic

The American Journal of Sports Medicine | August 2, 2018 | Volume: 46 | Issue: 11 | Pages: 2653-2660

10.1177/0363546518786035 | PMID 30070592 Get It

Background: Full-thickness radial meniscal tears render the meniscus nonfunctional and have historically been treated with partial meniscectomy. As preservative techniques evolve for radial repair, comparisons with other tear patterns are necessary to evaluate repair efficacy and prognosis. Purpose: To assess clinical outcomes and reoperation rates of radial meniscal repair and to compare them to bucket-handle meniscal repair. Study Design: Cohort study; Level of evidence, 3. Methods: Radial and bucket-handle meniscal tears without concurrent root injuries undergoing surgical repair at a single institution between 2007 and 2015 were analyzed, including both all-inside and inside-out suturing techniques. Propensity matching was performed on the basis of age at surgery, sex, meniscus laterality, body mass index (BMI), and concomitant anterior cruciate ligament reconstruction (ACLR) using a comparison pool of 70 bucket-handle repairs. Reoperation-free survival rates and Tegner, visual analog scale (VAS) for pain, and International Knee Documentation Committee (IKDC) scores were analyzed. Results: Twenty-four patients (18 male, 6 female; mean age, 22.8 ± 11.9 years) who underwent repair of a radial meniscal tear were followed for a mean of 3.5 years (range, 2.0-6.3 years). Significant postoperative improvements in VAS scores at rest and with use and IKDC scores were noted postoperatively ( P < .001). Five patients (20.8%) required a reoperation. Subsequently, 18 patients with radial tears (mean age, 19.1 ± 9.1 years; 12 male; mean BMI, 27.0 ± 6.2 kg/m 2 ; 3 medial; 11 ACLR) were propensity matched to 18 patients with bucket-handle tears (mean age, 20.8 ± 5.1 years; 13 male; mean BMI, 25.0 ± 3.5 kg/m 2 ; 3 medial; 11 ACLR). The matched radial and bucket-handle groups demonstrated similar ( P = .17) reoperation-free survival rates at 2 years (88.9% and 94.4%, respectively) and 5 years (77.8% and 87.7%, respectively). VAS and IKDC scores improved significantly after surgery ( P < .001), with no difference noted between the groups ( P ≥ .17). Patients with radial and bucket-handle meniscal repairs achieved mean postoperative Tegner scores (6.6 and 6.6, respectively) not significantly different from their preinjury levels (6.9 and 6.7, respectively) ( P ≥ .32). Conclusion: Satisfactory clinical outcomes are achievable for radial meniscal tear repair at short-term follow-up. In a robustly matched comparison, radial and bucket-handle meniscal tears demonstrate similar improvements in VAS and IKDC scores, restoration of preoperative Tegner scores, and acceptable reoperation rates. Full-thickness radial meniscal tears should be considered for repair.
A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses
McCarter, Stuart J. , Vijayvargiya, Prakhar , Sidana, Surbhi , Nault, Ashley M., Lane, Colleen E. , Lehman, Julia S. , Wilson, John , Nowakowski, Grzegorz S. , Al‐Kali, Aref , Al-Kali, Aref , Lehman, Julia S , Sidana, Surbhi , Parikh, Sameer A. , McCarter, Stuart J

Mayo Clinic

Leukemia & Lymphoma | August 2, 2018 | Volume: 60 | Issue: 2 | Pages: 559-561

10.1080/10428194.2018.1494271 | PMID 30070153 Get It

Uncoupled Endothelial Nitric Oxide Synthase Enhances p-Tau in Chronic Traumatic Encephalopathy Mouse Model
Shin, Nara , Kim, Hyeong-Geug , Kwon, Hyeok Hee , Yi, Min‐Hee , Zhang, Enji, Kim, Jwa-Jin, Hong, Jinpyo , Lee, Sun Yeul , Lee, Won Hyung , Triantafillu, Ursula L., Kim, Cuk‐Seong , Kim, Yonghyun , Kim, Dong Woon , Kim, Yonghyun , Kim, Dong Woon , Shin, Hyo Jung , Kim, Sena , Baek, Hyunjung

Mayo Clinic

Antioxidants & Redox Signaling | August 2, 2018 | Volume: 30 | Issue: 13 | Pages: 1601-1620

10.1089/ars.2017.7280 | PMID 30070145 Get It

Aims: Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease thought to be caused by repetitive traumatic brain injury (TBI) and subconcussive injuries. While hyperphosphorylation of tau (p-Tau), which is attributed to astrocytic tangles (ATs) and neurofibrillary tangles, is known to be involved in CTE, there are limited neuropathological or molecular data. By utilizing repetitive mild TBI (rmTBI) mouse models, our aim was to examine the pathological changes of CTE-associated structures, specifically the ATs. Results: Our rmTBI mouse models showed symptoms of depressive behavior and memory deficit, alongside an increased p-Tau expression in their neurons and astrocytes in both the hippocampus and cortex. rmTBI induced oxidative stress in endothelial cells and nitric oxide (NO) generation in astrocytes, which were mediated by hypoxia and increased hypoxia-inducible factor 1-α (HIF1α). There was also correlated decreased regional cerebral tissue perfusion units, mild activation of astrocytes and NFκB phosphorylation, increased expression of inducible nitric oxide synthase (iNOS), increased endothelial nitric oxide synthase (eNOS) uncoupling with decreased tetrahydrobiopterin, and increased expression of nitrotyrosine, NADPH oxidase 2 (Nox2)/nuclear factor (erythroid-derived 2) factor 2 (Nrf2) signaling proteins. Combined, these effects induced peroxynitrite formation and hyperphosphorylation of tau in the hippocampus and cortex toward the formation of ATs. Innovation: Our model features molecular pathogenesis events of CTE with clinically relevant latency periods. In particular, this is the first demonstration of an increased astrocytic iNOS expression in an in vivo model. Conclusion: We propose a novel mechanism of uncoupled eNOS and NO contribution to Tau phosphorylation and AT formation in rmTBI brain, toward an increased molecular understanding of the pathophysiology of human CTE.
Edonerpic Maleate: A Promising Pharmacological Agent for Stroke Recovery
Sattur, Mithun G. , Abi-Aad, Karl R., Bendok, Bernard R. , Pines, Andrew R.

Mayo Clinic

Neurosurgery | August 1, 2018 | Volume: 84 | Issue: 1 | Pages: E3-E4

10.1093/neuros/nyy397 | PMID 30551191 Get It

Deliberating Death in the Summer of 1968
Wijdicks, Eelco F. M.

Mayo Clinic

New England Journal of Medicine | August 1, 2018 | Volume: 379 | Issue: 5 | Pages: 412-415

10.1056/nejmp1802952 | PMID 30067926 Get It

Corrigan’s Pulse and Quincke’s Pulse
Enriquez‐Sarano, Maurice , Enriquez-Sarano, Maurice , Michelena, Héctor I.

Mayo Clinic

New England Journal of Medicine | August 1, 2018 | Volume: 379 | Issue: 5 | Pages: No page available

10.1056/nejmicm1715353 | PMID 30067925 Get It

Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry
Sharma, Anu , Kapoor, Ekta , Chang, Alice Y. , Erickson, Dana , Singh, Ravinder

Mayo Clinic

Clinical Chemistry | August 1, 2018 | Volume: 64 | Issue: 11 | Pages: 1636-1645

10.1373/clinchem.2018.290825 | PMID 30068692 Get It

Abstract BACKGROUND Previously defined thresholds for total testosterone (TT) concentrations to screen for androgen-producing tumors (APTs) have used RIA, which can be less accurate in women. We aimed to define diagnostic thresholds to screen for APTs or postmenopausal pathologic hyperandrogenism using TT concentrations measured by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). METHODS We performed a retrospective cohort study on all women with TT ≥3.5 nmol/L and all postmenopausal women presenting with hyperandrogenism between 2004 and 2014 at the Mayo Clinic in Rochester, MN. RESULTS Of the 369 women with TT ≥3.5 nmol/L, 89 were included and subdivided into 3 groups based on their clinical diagnosis [21 (24%), APT; 16 (18%), postmenopausal pathologic hyperandrogenism; 52 (58%), polycystic ovary syndrome]. The source of the APT was more frequently ovarian (81%, n = 17) than adrenal (19%, n = 4). The diagnostic threshold using ROC analysis for TT to identify APT in women with severe biochemical hyperandrogenemia was ≥5.1 nmol/L (sensitivity, 90%; specificity, 81%). In a second analysis of a cohort of postmenopausal women only presenting with symptoms or signs of hyperandrogenism, median TT was significantly higher in the postmenopausal pathologic hyperandrogenism group (APT and ovarian hyperthecosis) vs the idiopathic hyperandrogenism group (4.9 vs 0.8 nmol/L; P &lt; 0.01). In postmenopausal women, the diagnostic threshold for pathologic hyperandrogenism was TT ≥2.2 nmol/L (sensitivity, 100%; specificity, 86%). CONCLUSIONS The diagnostic threshold for TT concentration as measured by LC-MS/MS to identify APT in women with biochemical severe hyperandrogenemia was TT ≥5.1 nmol/L. In postmenopausal women, the diagnostic threshold for pathologic hyperandrogenism was lower (TT ≥2.2 nmol/L).
Your brain scan may be a reflection of your genes
Lowe, Val J. , Kandimalla, Karunya K. , Kandimalla, Karunya K , Kalari, Krishna R.

Mayo Clinic

Brain | August 1, 2018 | Volume: 141 | Issue: 9 | Pages: 2539-2541

10.1093/brain/awy226 | PMID 30169591 Get It

Extensor Mechanism Reconstruction with Use of Marlex Mesh
Abdel, Matthew P. , Salib, Christopher G. , Mara, Kristin C. , Pagnano, Mark W. , Perry, Kevin I. , Hanssen, Arlen D. , Mara, Kristin C. , Abdel, Matthew P , Mara, Kristin C , Mara, Kristin C.

Mayo Clinic

Journal of Bone and Joint Surgery | August 1, 2018 | Volume: 100 | Issue: 15 | Pages: 1309-1318

10.2106/jbjs.17.01165 | PMID 30063593 Get It

Background: Disruption of the extensor mechanism after total knee arthroplasty (TKA) is debilitating, and the reported results of numerous reconstructive options have varied. We previously reported the early results of 13 patients who underwent reconstruction of the extensor mechanism with use of Marlex mesh. The purpose of the current study was to assess results in a larger cohort of patients, with an emphasis on the survivorship of the mesh, clinical results, and complications. Methods: During the period of 2000 to 2015 at a single tertiary care academic institution, 77 patients (77 TKAs) underwent reconstruction with use of Marlex mesh for an extensor mechanism disruption (27 quadriceps tendon disruptions, 40 patellar tendon disruptions, and 10 patellar fractures). The mean patient age at the time of reconstruction was 65 years; 70% of the patients were female. The mean body mass index was 35 kg/m 2 . The mean follow-up was 4 years. Eighteen (23%) of the patients underwent mesh reconstruction with the primary TKA in place, and 59 (77%) had mesh reconstruction at the time of revision TKA. The mean time between disruption and reconstruction was 7 months. Twenty (26%) of the patients had previously undergone attempted extensor mechanism reconstruction at outside institutions. Results: Sixty-five of the 77 mesh reconstructions were in place at the time of the latest follow-up. Twelve patients experienced a failure that required mesh revision: 5 for patellar tendon rupture, 5 for quadriceps tendon rupture, and 2 for symptomatic lengthening. Four additional patients with mesh failure were treated nonoperatively with bracing. The 2-year survivorship free of mesh revision was 86% for patients with no prior reconstruction and 95% for patients with previous reconstructions of the extensor mechanism that did not involve Marlex mesh. Knee Society Score (KSS) results significantly improved following reconstruction (p < 0.001). Extensor lag improved by a mean of 26°, with mean postoperative extensor lag measuring 9° (p < 0.001). Conclusions: Reconstruction of the extensor mechanism with use of Marlex mesh is a viable option in patients with catastrophic disruption after TKA. At the time of the latest follow-up, 84% of the mesh reconstructions were in place and the functional outcomes were excellent, with mean improvement in extensor lag of 26°. Extended follow-up is required, but the results of this large series with a mean follow-up of 4 years are encouraging. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.